Epileptiform EEG discharges and sevoflurane in children: Protocol of a systematic review and meta-analysis

Mengrong Miao1,2, Yuehua Xu2,3, Xuhui Cong2

  • 1Department of Anesthesia and perioperative medicine, Henan University People's Hospital, Henan Provincial People's Hospital of Henan University.

Medicine
|October 3, 2019
PubMed

Insights

This systematic review examines sevoflurane's potential to cause epileptiform discharges in children's EEGs. It aims to clarify the incidence, characteristics, and risk factors of these events during anesthesia.

Area of Science:

  • Anesthesiology
  • Pediatric Neurology
  • Clinical Neurophysiology

Background:

  • Epileptiform discharges on electroencephalogram (EEG) are noted during sevoflurane mask induction in children.
  • The precise incidence, characteristics, and risk factors of these EEG patterns under sevoflurane anesthesia remain unclear.
  • Understanding these effects is crucial for pediatric anesthesia safety.

Purpose of the Study:

  • To systematically review the epileptic potential of sevoflurane in pediatric patients.
  • To determine the incidence, characteristics, and risk factors of epileptiform discharges during sevoflurane anesthesia.
  • To provide evidence-based insights for clinical practice.

Main Methods:

  • Systematic literature search of PubMed, EMBASE, and Cochrane Library (Central) up to December 2018.
  • Focus on studies monitoring EEG during sevoflurane anesthesia in children.
  • Meta-analysis planned using R software for quantitative synthesis.

Main Results:

  • This review will provide novel evidence regarding the incidence of EEG epileptic discharges.
  • It will detail the specific characteristics of these discharges.
  • Risk factors associated with sevoflurane-induced epileptiform activity will be identified.

Conclusions:

  • The findings will enhance understanding of sevoflurane's neurological effects in children.
  • This systematic review will inform anesthetic management for pediatric patients, including those with epilepsy.
  • Results will aid clinicians in mitigating potential risks associated with sevoflurane.
Abstract